Glyco-nanomaterials: Translating insights from the sugar-code to biomedical applications

Current Medicinal Chemistry

Volumn 18, Issue 14, 2011, Pages 2060-2078

  El Boubbou, Kheireddine ^a   Huang, Xuefei ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Glyco carbon nanotubes; Glyco dendrimers; Glyco nanomaterials; Glyco quantum dots; Gold glyconanoparticles; Magnetic glyconanoparticles; Magnetic resonance imaging; Sugar code

Indexed keywords

CARBOHYDRATE; CARBON NANOTUBE; DENDRIMER; GLYCONANOMATERIAL; GOLD NANOPARTICLE; LECTIN; MAGNETIC NANOPARTICLE; NANOMATERIAL; QUANTUM DOT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIUM DETECTION; CANCER CELL; DECOMPOSITION; GENETIC TRANSFECTION; IN VITRO STUDY; LECTIN BINDING; MESENCHYMAL STEM CELL; PRECIPITATION; PROTEIN CARBOHYDRATE INTERACTION; SYNTHESIS;

EID: 79957941341     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711795656144     Document Type: Article

References (208)

1. Pankhurst, Q. A.; Thanh, N. K. T.; Jones, S. K.; Dobson, J. Progress in Applications of Magnetic Nanoparticles in Biomedicine; J. Phys. D: Appl. Phys. 2009, 42, 224001
2. Huang, X.; Neretina, S.; El-Sayed, M. A. Gold Nanorods: from Synthesis and Properties to Biological and Biomedical Applications; Adv. Mater. 2009, 21, 4880-4910 and references therein.
3. Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an Emerging Platform for Cancer Therapy; Nat. Nanotech. 2007, 2, 751-760. (Pubitemid 350223348)
4. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges; Nature Rev. Cancer 2005, 5, 161-171. (Pubitemid 40314948)
5. Gabius, H.-J.; Siebert, H.-C.; André, S.; Jiménez-Barbero, J.; Rüdiger, H. Chemical Biology of the Sugar Code; ChemBioChem 2004, 5, 740-764. (Pubitemid 39257059)
6. Hakomori, S. Glycosylation Defining Cancer Malignancy: New Wine in an Old Bottle; Proc. Natl. Acad. Sci., USA 2002, 99, 10231-10233.
7. Dwek, R. A. Glycobiology: Toward Understanding the Function of Sugars; Chem. Rev. 1996, 96, 683-720. (Pubitemid 126649163)
8. For other reviews on this subject, see refs 8-10. García, I.; Marradi, M.; Penadés, S. Glyconanoparticles: Multifunctional Nanomaterials for Bomedical Applications; Nanomedicine 2010, 5, 777-792.
9. de la Fuente, J. M.; Penadés, S. Glyconanoparticles: Types, Synthesis and Applications in Glycoscience, Biomedicine and Material Science; Biochim. Biophys. Acta. 2006, 1760, 636-651 and references cited therein.
10. Larsen, K.; Thygesen, M. B.; Guillaumie, F.; Willats, W. G. T.; Jensen, K. J. Solid-phase Chemical Tools for Glycobiology; Carbohydr. Res. 2006, 341, 1209-1234. (Pubitemid 43795413)
11. Gabius, H.-J. Glycans: Bioactive Signals Decoded by Lectins; Biochem. Soc. Trans. 2008, 36, 1491-1496.
12. Varki, A. Biological Roles of Oligosaccharides: All of the Theories are Correct; Glycobiology 1993, 3, 97-130. (Pubitemid 23132602)
13. Seeberger, P. H.; Werz, D. B. Synthesis and Medical Applications of Oligosaccharides; Nature 2007, 446, 1046-1051. (Pubitemid 46676067)
14. Raman, R.; Sasisekharan, V.; Sasisekharan, R. Structural Insights into Biological Roles of Protein-Glycosaminoglycan Interactions; Chem. Biol. 2005, 12, 267-277. (Pubitemid 40406273)
15. Werz, D. B.; Seeberger, P. H. Carbohydrates as the Next Frontier in Pharmaceutical Research; Chem. Eur. J. 2005, 11, 3194-3206. (Pubitemid 40750980)
16. Koeller, K. M.; Wong, C.-H. Emerging Themes in Medicinal Glycoscience; Nature Biotech. 2000, 18, 835-841. (Pubitemid 30640907)
17. Rabinovich, G. A.; Toscano, M. A. Turning 'Sweet' on Immunity: Galectin- glycan Interactions in Immune Tolerance and Inflammation; Nature Rev. Cancer 2009, 9, 338-352.
18. Macher, B. A.; Galili, U. The Galα1,3Galβ1,4GlcNAc-R (α-Gal) Epitope: A Carbohydrate of Unique Evolution and Clinical Relevance; Biochim. Biophys. Acta 2008, 1780, 75-88.
19. Simanek, E. E.; McGarvey, G. J.; Jablonowski, J. A.; Wong, C.-H. SelectinαCarbohydrate Interactions: From Natural Ligands to Designed Mimics; Chem. Rev. 1998, 98, 833-862. (Pubitemid 128631443)
20. Nangia-Makker, P.; Conklin, J.; Hogan, V.; Raz, A. Carbohydrate-binding Proteins in Cancer, and Their Ligands as Therapeutic Agents; Trends Mol. Med. 2002, 8, 187-192. (Pubitemid 34297092)
21. Hakomori, S.-I.; Zhang, Y. Glycosphingolipid Antigens and Cancer Therapy; Chem. Biol. 1997, 4, 97-104. (Pubitemid 27161748)
22. Pieters, R. J. Maximising Multivalency Effects in Protein-carbohydrate Interactions; Org. Biomol. Chem. 2009, 7, 2013-2025.
23. Lingwood, C. A. Oligosaccharide Receptors for Bacteria: a View to a Kill; Curr. Opin. Chem. Biol. 1998, 2, 695-700. (Pubitemid 128646739)
24. Petitou, M.; van Beockel, C. A. A. A Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?; Angew. Chem. Int. Ed. 2004, 43, 3118-3133. (Pubitemid 39257600)
25. Mammen, M.; Choi, S. K.; Whitesides, G. M. Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors; Angew. Chem. Int. Ed. 1998, 37, 2754-2794. (Pubitemid 29008561)
26. Lee, Y. C.; Lee, R. T. Carbohydrate-Protein Interactions: Basis of Glycobiology; Acc. Chem. Res. 1995, 28, 321-7.
27. Lundquist, J. J.; Toone, E. J. The Cluster Glycoside Effect; Chem. Rev. 2002, 102, 555-578. (Pubitemid 35377623)
28. Iqbal, S. S.; Mayo, M. W.; Bruno, J. G.; Bronk, B. V.; Batt, C. A.; Chambers, J. P. A Review of Molecular Recognition Technologies for Detection of Biological Threat Agents; Biosens. Bioelectron. 2000, 15, 549-578.
29. Wang, Z.; Huang, X. Strategies in Oligosaccharide Synthesis; In Comprehensive Glycoscience from Chemistry to Systems Biology Kamerling, J. P., Ed.; Elsevier: 2007; Vol. 1, p 379-413.
30. Laurent, S.; Forge, D.; Port, M.; Roch, A.; Robic, C.; Vander Elst, L.; Muller, R. N. Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications; Chem. Rev. 2008, 108, 2064-2110.
31. Jun, Y.-W.; Lee, J.-H.; Cheon, J. Chemical Design of Nanoparticle Probes for High-performance Magnetic Resonance Imaging; Angew. Chem., Int. Ed. 2008, 47, 5122-5135.
32. Lu, A. H.; Salabas, E. L.; Schueth, F. Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application; Angew. Chem., Int. Ed. 2007, 46, 1222-1244.
33. 4 Nanoparticles and Their Biomedical Applications; Biomaterials 2005, 26, 729-738.
34. Isaac, K.; Wang, X.; Varughese, B.; Isaacs, L.; Ehrman, S. H.; English, D. S. Magnetic Iron Oxide Nanoparticles for Biorecognition: Evaluation of Surface Coverage and Activity; J. Phys. Chem. B 2006, 110, 1553-1558. (Pubitemid 43235749)
35. Gupta, A. K.; Gupta, M. Synthesis and Surface Engineering of Iron Oxide Nanoparticles for Biomedical Applications; Biomaterials 2005, 26, 3995-4021. (Pubitemid 40044762)
36. Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine; Acc. Chem. Res. 2008, 41, 1578-1586.
37. Qian, X.; Peng, X.-H.; Ansari, D. O.; Yin-Goen, Q.; Chen, G. Z.; Shin, D. M.; Yang, L.; Young, A. N.; Wang, M. D.; Nie, S. In vivo Tumor Targeting and Spectroscopic Detection with Surface-enhanced Raman Nanoparticle Tags; Nat. Biotechnol. 2008, 26, 83-90.
38. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W. K.; Nie, S. In vivo Cancer Targeting and Imaging with Semiconductor Quantum Dots; Nature Biotechnol. 2004, 22, 969-976. (Pubitemid 39014473)
39. Qiao, R.; Yang, C.; Gao, M. Superparamagnetic Iron Oxide Nanoparticles: from Preparations to in vivo MRI Applications; J. Mater. Chem. 2009, 19, 6274-6293.
40. Lee, J.-H.; Huh, Y.-M.; Jun, Y.-w.; Seo, J.-w.; Jang, J.-t.; Song, H.-T.; Kim, S.; Cho, E.-J.; Yoon, H.-G.; Suh, J.-S.; Cheon, J. Artificially Engineered Magnetic Particles for Ultra-sensitive Molecular Imaging; Nat. Med. 2007, 13, 95-99. (Pubitemid 46067392)
41. Yang, L.; Peng, X.-H.; Wang, Y. A.; Wang, X.; Cao, Z.; Ni, C.; Karna, P.; Zhang, X.; Wood, W. C.; Gao, X.; Nie, S.; Mao, H. Receptor-Targeted Nanoparticles for In vivo Imaging of Breast Cancer; Clin. Cancer Res. 2009, 15, 4722-4732.
42. Stoeva, S. I.; Lee, J.-S.; Smith, J. E.; Rosen, S. T.; Mirkin, C. A. Multiplexed Detection of Protein Cancer Markers with Biobarcoded Nanoparticle Probes; J. Am. Chem. Soc. 2006, 128, 8378-8379.
43. van Kasteren, S. I.; Campbell, S. J.; Serres, S.; Anthony, D. C.; Sibson, N. R.; Davis, B. G. Glyconanoparticles Allow Pre-symptomatic in vivo Imaging of Brain Disease; Proc. Natl. Acad. Sci., USA 2009, 106, 18-23.
44. Paul, K. G.; Frigo, T. B.; Groman, J. Y.; Groman, E. V. Synthesis of Ultrasmall Superparamagnetic Iron Oxides Using Reduced Polysaccharides; Bioconjugate Chem. 2004, 15, 394-401. (Pubitemid 38365201)
45. Chen, Y.; Ji, T.; Rosenzweig, Z. Synthesis of Glyconanospheres Containing Luminescent CdSe-ZnS Quantum Dots; Nano Lett. 2003, 3, 581-584. (Pubitemid 37140618)
46. Hu, Y.; Jiang, X.; Ding, Y.; Ge, H.; Yuan, Y.; Yang, C. Synthesis and Characterization of Chitosan-poly(acrylic acid) Nanoparticles; Biomaterials 2002, 23, 3193-3201. (Pubitemid 34525103)
47. Moore, A.; Marecos, E.; Bogdanov, A., Jr.; Weissleder, R. Tumoral Distribution of Long-circulating Dextran-coated Iron Oxide Nanoparticles in a Rodent Model; Radiology 2000, 214, 568-574. (Pubitemid 30077721)
48. Wang, Y. X.; Hussain, S. M.; Krestin, G. P. Superparamagnetic Iron Oxide Contrast Agents: Physicochemical Characteristics and Applications in MR Imaging; Eur. Radiol. 2001, 11, 2319-31. (Pubitemid 33041104)
49. Lin, P.-C.; Tseng, M.-C.; Su, A.-K.; Chen, Y.-J.; Lin, C.-C. Functionalized Magnetic Nanoparticles for Small-Molecule Isolation, Identification, and Quantification; Anal. Chem. 2007, 3401-3408. (Pubitemid 46717171)
50. Perez, J. M.; Josephson, L.; O'Loughlin, T.; Hogemann, D.; Weissleder, R. Magnetic Relaxation Switches Capable of Sensing Molecular Interactions; Nat. Biotechnol. 2002, 20, 816-20. (Pubitemid 34836759)
51. Perez, J. M.; Josephson, L.; Weissleder, R. Use of Magnetic Nanoparticles as Sensors to Probe for Molecular Interactions; ChemBioChem 2004, 5, 261-264. (Pubitemid 39257117)
52. Jun, Y. W.; Huh, Y. M.; Choi, J. S.; Lee, J. H.; Song, H. T.; Kim, S.; Yoon, S.; Kim, K. S.; Shin, J. S.; Suh, J. S.; Cheon, J. Nanoscale Size Effect of Magnetic Nanocrystals and Their Utilization for Cancer Diagnosis via Magnetic Resonance Imaging; J. Am. Chem. Soc. 2005, 127, 5732-5733. (Pubitemid 40577599)
53. Yu, M. K.; Jeong, Y. Y.; Park, J.; Park, S.; Kim, J. W.; Min, J. J.; Kim, K.; Jon, S. Drug-loaded Superparamagnetic Iron Oxide Nanoparticles for Combined Cancer Imaging and Therapy in vivo; Angew. Chem., Int. Ed. 2008, 47, 5362-5365.
54. Park, J.-H.; von Maltzahn, G.; Zhang, L.; Schwartz, M. P.; Ruoslahti, E.; Bhatia, S. N.; Sailor, M. J. Magnetic Iron Oxide Nanoworms for Tumor Targeting and Imaging; Adv. Mater. 2008, 20, 1630-1635.
55. Gao, B. J.; Li, L.; Ho, P. L.; Mak, G. C.; Gu, H.; Xu, B. Combining Fluorescent Probes and Biofunctional Magnetic Nanoparticles for Rapid Detection of Bacteria in Human Blood; Adv. Mater. 2006, 18, 3145-3148. (Pubitemid 46080208)
56. 3 Nanoparticles with Tailored Functionality for Protein Separation; Chem. Commun. 2007, 4677-4679. (Pubitemid 350077027)
57. Massart, R. Preparation of aqueous magnetic liquids in alkaline and acidic media; IEEE Trans. Magn. 1981, 17, 1247-8. (Pubitemid 11497282)
58. Koh, I.; Wang, X.; Varughese, B.; Isaacs, L.; Ehrman, S. H.; English, D. S. Magnetic Iron Oxide Nanoparticles for Biorecognition: Evaluation of Surface Coverage and Activity; J. Phys. Chem. B 2006, 110, 1553-1558. (Pubitemid 43235749)
59. Bruce, I. J.; Sen, T. Surface Modification of Magnetic Nanoparticles with Alkoxysilanes and Their Application in Magnetic Bioseparations; Langmuir 2005, 21, 7029-7035. (Pubitemid 41084494)
60. Yamaura, M.; Camilo, R. L.; Sampaio, L. C.; Macedo, M. A.; Nakamura, M.; Toma, H. E. Preparation and Characterization of (3- Aminopropyl)triethoxysilane- coated Magnetite Nanoparticles; J. Magn. Magn. Mater. 2004, 279, 210-217.
61. Klotz, M.; Ayral, A.; Guizard, C.; Menager, C.; Cabuil, V. Silica Coating on Colloidal Maghemite Particles; J. Colloid Interface Sci. 1999, 220, 357-361. (Pubitemid 30045781)
62. Corot, C.; Robert, P.; Idee, J.-M.; Port, M. Recent Advances in Iron Oxide Nanocrystal Technology for Medical Imaging; Adv. Drug Delivery Rev. 2006, 58, 1471-1504. (Pubitemid 44820503)
63. Sun, S.; Zeng, H. Size-Controlled Synthesis of Magnetite Nanoparticles; J. Am. Chem. Soc. 2002, 124, 8204-8205. (Pubitemid 34875378)
64. 4 (M = Fe, Co, Mn) Nanoparticles; J. Am. Chem. Soc. 2004, 126, 273-279. (Pubitemid 38090367)
65. Hyeon, T.; Lee, S. S.; Park, J.; Chung, Y.; Na, H. B. Synthesis of Highly Crystalline and Monodisperse Maghemite Nanocrystallites without a Size- Selection Process; J. Am. Chem. Soc. 2001, 123, 12798-12801. (Pubitemid 34015142)
66. Park, J.; An, K.; Hwang, Y.; Park, J.-G.; Noh, H.-J.; Kim, J.-Y.; Park, J.-H.; Hwang, N.-M.; Hyeon, T. Ultra-large-scale Syntheses of Monodisperse Nanocrystals; Nature Mater. 2004, 3, 891-895.
67. De Palma, R.; Peeters, S.; Van Bael, M. J.; Van den Rul, H.; Bonroy, K.; Laureyn, W.; Mullens, J.; Borghs, G.; Maes, G. Silane Ligand Exchange to Make Hydrophobic Superparamagnetic Nanoparticles Water-dispersible; Chem. Mater. 2007, 19, 1821-1831. (Pubitemid 46608222)
68. Horák, D.; Babič, M.; Jendelová, P.; Herynek, V.; Trchová, M.; Pientka, Z.; Pollert, E.; Hájek, M.; Syková, E. D-Mannose-Modified Iron Oxide Nanoparticles for Stem Cell Labeling; Bioconjugate Chem. 2007, 18, 635-644. (Pubitemid 47010781)
69. Palmacci, S.; Josephson, L.; Groman, E. V. Synthesis of polymer-covered superparamagnetic oxide colloids for magnetic resonance contrast agents or other applications; (Advanced Magnetics, Inc., USA). 1995; US Patent WO/1995/005669, p 45 pp.
70. Shi, Z.; Neoh, K. G.; Kang, E. T.; Shuter, B.; Wang, S.-C.; Poh, C.; Wang, W. (Carboxymethyl)chitosan-Modified Superparamagnetic Iron Oxide Nanoparticles for Magnetic Resonance Imaging of Stem Cells; ACS Appl. Mater. Interface. 2009, 1, 328-335.
71. Srinivasan, B.; Huang, X. Functionalization of magnetic nanoparticles with organic molecules: loading level determination and evaluation of linker length effect on immobilization; Chirality 2008, 20, 265-277. (Pubitemid 351303963)
72. El-Boubbou, K.; Zhu, D. C.; Vasileiou, C.; Borhan, B.; Prosperi, D.; Li, W.; Huang, X. Magnetic Glyco-nanoparticles: a Tool to Detect, Differentiate, and Unlock the Glyco-codes of Cancer via Magnetic Resonance Imaging; J. Am. Chem. Soc. 2010, 132, 4490-4499.
73. El-Boubbou, K.; Gruden, C.; Huang, X. Magnetic Glyco-nanoparticles: A Unique Tool for Rapid Pathogen Detection, Decontamination, and Strain Differentiation; J. Am. Chem. Soc. 2007, 129, 13392-13393. (Pubitemid 350071759)
74. Lin, P.-C.; Ueng, S.-H.; Yu, S.-C.; Jan, M.-D.; Adak, A. K.; Yu, C.-C.; Lin, C.-C. Surface Modification of Magnetic Nanoparticle via Cu(I)-Catalyzed Alkyne-azide [2 + 3] Cycloaddition; Org. Lett. 2007, 9, 2131-2134.
75. Pera, N. P.; Kouki, A.; Haataja, S.; Branderhorst, H. M.; Liskamp, R. M. J.; Visser, G. M.; Finne, J.; Pieters, R. J. Detection of Pathogenic Streptococcus suis Bacteria using Magnetic Glycoparticles; Org. Biomol. Chem. 2010, 8, 2425-2429.
76. Hatch, D. M.; Weiss, A. A.; Kale, R. R.; Iyer, S. S. Biotinylated Bi- and Tetra-antennary Glycoconjugates for Escherichia coli Detection; ChemBioChem 2008, 9, 2433-2442.
77. Liu, L.-H.; Dietsch, H.; Schurtenberger, P.; Yan, M. Photoinitiated Coupling of Unmodified Monosaccharides to Iron Oxide Nanoparticles for Sensing Proteins and Bacteria; Bioconjugate Chem. 2009, 20, 1349-1355.
78. Shimura, K.; Kasai, K. Determination of the Affinity Constants of Concanavalin A for Monosaccharides by Fluorescence Affinity Probe Capillary Electrophoresis; Anal. Biochem. 1995, 227, 186-194.
79. Finlay, B. B.; Cossart, P. Exploitation of Mammalian Host Cell Functions by Bacterial Pathogens; Science 1997, 276, 718-725. (Pubitemid 27199840)
80. Beachey, E. H. Bacterial Adherence: Adhesin-receptor Interactions Mediating the Attachment of Bacteria to Mucosal Surfaces; J. Infect. Dis. 1981, 143, 325-45. (Pubitemid 11113653)
81. Levy, S. B. Antibiotic Resistance - the Problem Intensifies; Adv. Drug Delivery Rev. 2005, 57, 1446-1450. (Pubitemid 40984600)
82. Harris, S. L.; Spears, P. A.; Havell, E. A.; Hamrick, T. S.; Horton, J. R.; Orndorff, P. E. Characterization of Escherichia coli Type 1 Pilus Mutants with Altered Binding Specificities; J. Bacteriol. 2001, 183, 4099-4102. (Pubitemid 32565492)
83. Lee, Y.; Lee, H.; Kim, Y. B.; Kim, J.; Hyeon, T.; Park, H.; Messersmith, P. B.; Park, T. G. Bioinspired Surface Immobilization of Hyaluronic Acid on Monodisperse Magnetite Nanocrystals for Targeted Cancer Imaging; Adv. Mater. 2008, 20, 4154-4157.
84. Sy, M.-S.; Mori, H.; Liu, D. CD44 as a Marker in Human Cancers; Curr. Opin. Oncol. 1997, 9, 108-112. (Pubitemid 27142561)
85. 3 Hybrid Magnetic Nanoparticles for Targeted Delivery of Peptides; Nanomedicine 2007, 3, 132-137. (Pubitemid 46899611)
86. Kamat, M.; El-boubbou, K.; Zhu, D. C.; Lansdell, T.; Lu, X.; Li, W.; Huang, X. Hyaluronic Acid Immobilized Magnetic Nanoparticles for Active Targeting and Imaging of Macrophages; Bioconjugate Chem. 2010, 21, 2128-2135.
87. Wright, A. T.; Anslyn, E. V. Differential Receptor Arrays and Assays for Solution-based Molecular Recognition; Chem. Soc. Rev. 2006, 35, 14-28. (Pubitemid 43485010)
88. Lu, C.-W.; Hung, Y.; Hsiao, J.-K.; Yao, M.; Chung, T.-H.; Lin, Y.-S.; Wu, S.-H.; Hsu, S.-C.; Liu, H.-M.; Mou, C.-Y.; Yang, C.-S.; Huang, D.-M.; Chen, Y.-C. Bifunctional Magnetic Silica Nanoparticles for Highly Efficient Human Stem Cell Labeling; Nano Lett. 2007, 7, 149-154. (Pubitemid 46225844)
89. Song, H.-T.; Choi, J.-s.; Huh, Y.-M.; Kim, S.; Jun, Y.-w.; Suh, J.-S.; Cheon, J. Surface Modulation of Magnetic Nanocrystals in the Development of Highly Efficient Magnetic Resonance Probes for Intracellular Labeling; J. Am. Chem. Soc. 2005, 127, 9992-9993. (Pubitemid 40995431)
90. Babi, M.; Horák, D.; Trchová, M.; Jendelová, P.; Glogarová, K.; Lesný, P.; Herynek, V.; Hájek, M.; Syková, E. Poly(l-lysine)-Modified Iron Oxide Nanoparticles for Stem Cell Labeling; Bioconjugate Chem. 2008, 19, 740-750. (Pubitemid 351431406)
91. Park, B. H. J., J. C.; Lee, G. H.; Kim, T. J.; Lee, Y. J.; Kim, J. Y.;; Kim, Y. W. J., J. H.; Chang, Y. M. Comparison of Labeling Efficiency of Different Magnetic Nanoparticles into Stem Cell; Colloids Surf., A 2008, 313-314, 145-149.
92. Yoo, M. K.; Kim, I. Y.; Kim, E. M.; Jeong, H.-J.; Lee, C.-M.; Jeong, Y. Y.; Akaike, T.; Cho, C. S. Superparamagnetic Iron Oxide Nanoparticles Coated with Galactose-carrying Polymer for Hepatocyte Targeting; J. Biomed. Biotechnol. 2007, 94740.
93. Lee, R. T.; Myers, R. W.; Lee, Y. C. Further Studies on the Binding Characteristics of Rabbit Liver Galactosyl N-Acetylgalactosamine-Specific Lectin; Biochemistry 1982, 21, 6292-6298.
94. Yoo, M. K.; Park, I. Y.; Kim, I. Y.; Park, I. K.; Kwon, J.-S.; Jeong, H.-J.; Jeong, Y. Y.; Cho, S. C. Superparamagnetic Iron Oxide Nanoparticles Coated with Mannan for Macrophage Targeting; J. Nanosci. Nanotechnol. 2008, 8, 5196-5202.
95. Barthel, S. R.; Gavino, J. D.; Descheny, L.; Dimitroff, C. J. Targeting Selectins and Selectin Ligands in Inflammation and Cancer; Exp. Opin. Ther. Targets 2007, 11, 1473-1491. (Pubitemid 350200482)
96. Eustis, S.; El-Sayed, M. A. Why Gold Nanoparticles are More Precious than Pretty Gold: Noble Metal Surface Plasmon Resonance and its Enhancement of the Radiative and Nonradiative Properties of Nanocrystals of Different Shapes; Chem. Soc. Rev. 2006, 35, 209-217. (Pubitemid 43327142)
97. Nikoobakht, B.; El-Sayed, M. A. Surface-Enhanced Raman Scattering Studies on Aggregated Gold Nanorods; J. Phys. Chem. A 2003, 107, 3372-3378.
98. Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer Cell Imaging and Photothermal Therapy in the Near-Infrared Region by Using Gold Nanorods; J. Am. Chem. Soc. 2006, 128, 2115-2120. (Pubitemid 43277351)
99. Thompson, D. Michael Faraday's Recognition of Ruby Gold: the Birth of Modern Nanotechnology; Gold Bull. 2007, 40, 267-269.
100. Grzelczak, M.; Pérez-Juste, J.; Mulvaney, P.; Liz-Marzán, L. M. Shape Control in Gold Nanoparticle Synthesis; Chem. Soc. Rev. 2008, 37, 1783 - 1791.
101. Ghosh, S. K.; Pal, T. Interparticle Coupling Effect on the Surface Plasmon Resonance of Gold Nanoparticles: From Theory to Applications; Chem. Rev. 2007, 107, 4797-4862. (Pubitemid 350237041)
102. Daniel, M.-C.; Astruc, D. Gold Nanoparticles: Assembly, Supramolecular Chemistry, Quantum-Size-Related Properties, and Applications toward Biology, Catalysis, and Nanotechnology; Chem. Rev. 2004, 104, 293-346.
103. Frens, G. Controlled Nucleation for the Regulation of the Particle Size in Monodisperse Gold Suspensions; Nature 1973, 241, 20-2.
104. Turkevich, J.; Stevenson, P. C.; Hillier, J. The Nucleation and Growth Processes in the Synthesis of Colloidal Gold; Discuss. Faraday Soc. 1951, 11, 55-75.
105. Turkevich, J.; Hubbell, H. H. Low-angle x-ray Diffraction of Colloidal Gold and Carbon Black; J. Am. Chem. Soc. 1951, 73, 1-7.
106. Brust, M.; Walker, M.; Bethell, D.; Schiffrin, D. J.; Whyman, R. Synthesis of Thiol-derivatized Gold Nanoparticles in a Two-phase Liquid-liquid System; Chem. Commun. 1994, 801-802.
107. Brown, K. R.; Walter, D. G.; Natan, M. J. Seeding of Colloidal Au Nanoparticle Solutions. 2. Improved Control of Particle Size and Shape; Chem. Mater. 2000, 12, 306-313.
108. Goia, D. V.; Matijevic, E. Tailoring the Particle Size of Monodispersed Colloidal Gold; Colloids Surf., A 1999, 146, 139-152. (Pubitemid 29083113)
109. de la Fuente, J. M.; Alcantara, D.; Penadés, S. Cell Response to Magnetic Glyconanoparticles: Does the Carbohydrate Matter?; IEEE Trans. Nanobioscience 2007, 6, 275-281. (Pubitemid 350210545)
110. Halkes, K. M.; Carvalho de Souza, A.; Elizabeth, C.; Maliaars, P.; Gerwig, G. J.; Kamerling, J. P. A Facile Method for the Preparation of Gold Glyconanoparticles from Free Oligosaccharides and Their Applicability in Carbohydrate-protein Interaction Studies; Eur. J. Org. Chem. 2005, 3650-3659. (Pubitemid 41342387)
111. Svarovsky, S. A.; Szekely, Z.; Barchi, J. J. Synthesis of Gold Nanoparticles Bearing the Thomsen-Friedenreich Disaccharide: a New Multivalent Presentation of an Important Tumor Antigen; Tetrahedron Asymm. 2005, 16, 587-598. (Pubitemid 40174837)
112. Chen, Y.-J.; Chen, S.-H.; Chien, Y.-Y.; Chang, Y.-W.; Liao, H.-K.; Chang, C.-Y.; Jan, M.-D.; Wang, K.-T.; Lin, C.-C. Carbohydrate-encapsulated Gold Nanoparticles for Rapid Target-protein Identification and Binding-epitope Mapping; ChemBioChem 2005, 6, 1169-1173. (Pubitemid 40978174)
113. Nolting, B.; Yu, J.-J.; Liu, G.-Y.; Cho, S.-J.; Kauzlarich, S.; Gervay-Hague, J. Synthesis of Gold Glyconanoparticles and Biological Evaluation of Recombinant gp120 Interactions; Langmuir 2003, 19, 6465-6473.
114. de la Fuente, J. M.; Barrientos, A. G.; Rojas, T. C.; Rojo, J.; Canada, J.; Fernandez, A.; Penadés, S. Gold Glyconanoparticles as Water-soluble Polyvalent Models to Study Carbohydrate Interactions; Angew. Chem. Int. Ed. 2001, 40, 2257-2261.
115. Sundgren, A.; Barchi, J. J. Varied Presentation of the Thomsen-Friedenreich Disaccharide Tumor-associated Carbohydrate Antigen on Gold Nanoparticles; Carbohydr. Res. 2008, 343, 1594-1604.
116. Mahon, E.; Aastrup, T.; Barboiu, M. Multivalent Recognition of Lectins by Glyconanoparticle Systems; Chem. Commun. 2010, 5491-5493.
117. Thygesen, M. B.; Sørensen, K. K.; Cló, E.; Jensen, K. J. Direct Chemoselective Synthesis of Glyconanoparticles from Unprotected Reducing Glycans and Glycopeptide Aldehydes; Chem. Commun. 2009, 6367-6369.
118. Thygesen, M. B.; Sauer, J.; Jensen, K. J. Chemoselective Capture of Glycans for Analysis on Gold Nanoparticles: Carbohydrate Oxime Tautomers Provide Functional Recognition by Proteins; Chem. Eur. J. 2009, 15, 1649 - 1660.
119. Chien, Y.-Y.; Jan, M.-D.; Adak, A. K.; Tzeng, H.-C.; Lin, Y.-P.; Chen, Y.-J.; Wang, K.-T.; Chen, C.-T.; Chen, C.-C.; Lin, C.-C. Globotriosefunctionalized Gold Nanoparticles as Multivalent Probes for Shiga-like Toxin; ChemBioChem 2008, 9, 1100-1109.
120. Hone, D. C.; Haines, A. H.; Russell, D. A. Rapid, Quantitative Colorimetric Detection of a Lectin Using Mannose-Stabilized Gold Nanoparticles; Langmuir 2003, 19, 7141-7144.
121. Kemp, M. M.; Kumar, A.; Mousa, S.; Dyskin, E.; Yalcin, M.; Ajayan, P.; Linhardt, R. J.; Mousa, S. A. Gold and Silver Nanoparticles Conjugated with Heparin Derivative Possess Anti-angiogenesis Properties; Nanotech. 2009, 20, 455104.
122. Guo, Y.; Yan, H. Preparation and Characterization of Heparin-Stabilized Gold Nanoparticles; J. Carbohydr. Chem. 2008, 27, 309-319.
123. x determinant antigens as measured by atomic force microscopy; Angew. Chem. Int. Ed. 2001, 40, 3052-3055. (Pubitemid 32802949)
124. XGold Glyconanoparticles. A Model for Cell Adhesion via Carbohydrate- Carbohydrate Interaction; J. Am. Chem. Soc. 2005, 127, 6192-6197. (Pubitemid 40627741)
125. Hernaiz, M. J.; de la Fuente, J. M.; Barrientos, A. G.; Penadés, S. A Model System Mimicking Glycosphingolipid Clusters to Quantify Carbohydrate Self-interactions by Surface Plasmon Resonance; Angew. Chem. Int. Ed. 2002, 41, 1554-1557. (Pubitemid 34534398)
126. de Souza, A. C.; Halkes, K. M.; Meeldijk, J. D.; Verkleij, A. J.; Vliegenthart, J. F. G.; Kamerling, J. P. Gold Glyconanoparticles as Probes to Explore the Carbohydrate-mediated Self-recognition of Marine Sponge Cells; ChemBioChem 2005, 6, 828-831. (Pubitemid 40873741)
127. Lin, C.-C.; Yeh, Y.-C.; Yang, C.-Y.; Chen, G.-F.; Chen, Y.-C.; Wu, Y.-C.; Chen, C.-C. Quantitative Analysis of Multivalent Interactions of Carbohydrate-encapsulated Gold Nanoparticles with Concanavalin A; Chem. Commun. 2003, 2920-2921. (Pubitemid 37492859)
128. Liang, C.-H.; Wang, C.-C.; Lin, Y.-C.; Chen, C.-H.; Wong, C.-H.; Wu, C.-Y. Iron Oxide/Gold Core/Shell Nanoparticles for Ultrasensitive Detection of Carbohydrate-Protein Interactions; Anal. Chem. 2009, 81, 7750-7756.
129. Schofield, C. L.; Haines, A. H.; Field, R. A.; Russell, D. A. Silver and Gold Glyconanoparticles for Colorimetric Bioassays; Langmuir 2006, 22, 6707-6711. (Pubitemid 44146909)
130. Sato, Y.; Murakami, T.; Yoshioka, K.; Niwa, O. 12-Mercaptododecyl α- Maltoside-modified Gold Nanoparticles: Specific Ligands for Concanavalin A Having Long Flexible Hydrocarbon Chains Anal. Bioanal. Chem. 2008, 391, 2527-2532.
131. Springer, G. F. Immunoreactive T and Tn epitopes in cancer diagnosis, prognosis, and immunotherapy; J. Mol. Med. 1997, 75, 594-602. (Pubitemid 27373602)
132. de la Fuente, J. M.; Alcantara, D.; Eaton, P.; Crespo, P.; Rojas, T. C.; Fernandez, A.; Hernando, A.; Penadés, S. Gold and Gold-Iron Oxide Magnetic Glyconanoparticles: Synthesis, Characterization and Magnetic Properties; J. Phys. Chem. B 2006, 110, 13021-13028. (Pubitemid 44115637)
133. Martinez-Avila, O.; Hijazi, K.; Marradi, M.; Clavel, C.; Campion, C.; Kelly, C.; Penadés, S. Gold Manno-glyconanoparticles: Multivalent Systems to Block HIV-1 gp120 Binding to the Lectin DC-SIGN; Chem. Eur. J. 2009, 15, 9874-9888.
134. Feinberg, H.; Mitchell, D. A.; Drickamer, K.; Weis, W. I. Structural Basis for Selective Recognition of Oligosaccharides by DC-SIGN and DC-SIGNR; Science 2001, 294, 2163-2166. (Pubitemid 33150672)
135. Martinez-Avila, O.; Bedoya, L. M.; Marradi, M.; Clavel, C.; Alcami, J.; Penadés, S. Multivalent Manno-Glyconanoparticles Inhibit DC-SIGNMediated HIV-1 Trans-Infection of Human T Cells; ChemBioChem 2009, 10, 1806-1809.
136. Lin, C. C.; Yeh, Y. C.; Yang, C. Y.; Chen, C. L.; Chen, G. F.; Chen, C. C.; Wu, Y. C. Selective Binding of Mannose-Encapsulated Gold Nanoparticles to Type 1 Pili in Escherichia coli; J. Am. Chem. Soc. 2002, 124, 3508-3509.
137. Schofield, C. L.; Field, R. A.; Russell, D. A. Glyconanoparticles for the Colorimetric Detection of Cholera Toxin; Anal. Chem. 2007, 79, 1356-1361 and references cited therein.
138. Nath, S.; Kaittanis, C.; Tinkham, A.; Perez, J. M. Dextran-Coated Gold Nanoparticles for the Assessment of Antimicrobial Susceptibility; Anal. Chem. 2008, 80, 1033-1038. (Pubitemid 351272335)
139. Ahmed, M.; Deng, Z.; Liu, S.; Lafrenie, R.; Kumar, A.; Narain, R. Cationic Glyconanoparticles: Their Complexation with DNA, Cellular Uptake, and Transfection Efficiencies; Bioconjugate Chem. 2009, 20, 2169-2176.
140. Eaton, P.; Ragusa, A.; Clavel, C.; Rojas Cristina, T.; Graham, P.; Duran Raul, V.; Penadés, S. Glyconanoparticle-DNA interactions: an atomic force microscopy study; IEEE Trans Nanobioscience 2007, 6, 309-18. (Pubitemid 350210546)
141. de la Fuente, M.; Seijo, B.; Alonso, M. J. Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy; Invest. Ophthalmol. Vis. Sci. 2008, 49, 2016-24.
142. de la Fuente, M.; Seijo, B.; Alonso, M. J. Bioadhesive Hyaluronan-chitosan Nanoparticles can Transport Genes Across the Ocular Mucosa and Transfect Ocular Tissue; Gene Ther. 2008, 15, 668-676. (Pubitemid 351524521)
143. Lee, H.; Lee, K.; Kim, I. K.; Park, T. G. Synthesis, Characterization, and in vivo Diagnostic Applications of Hyaluronic Acid Immobilized Gold Nanoprobes; Biomaterials 2008, 29, 4709-4718.
144. Marradi, M.; Alcantara, D.; de la Fuente, J. M.; Garcia-Martin, M. L.; Cerdan, S.; Penadés, S. Paramagnetic Gd-based Gold Glyconanoparticles as Probes for MRI: Tuning Relaxivities with Sugars; Chem. Commun. 2009, 3922-3924.
145. Rojo, J.; Diaz, V.; de la Fuente, J. M.; Segura, I.; Barrientos, A. G.; Riese, H. H.; Bernad, A.; Penadés, S. Gold Glyconanoparticles as New Tools in Antiadhesive Therapy; ChemBioChem 2004, 5, 291-297. (Pubitemid 39257122)
146. Wang, Z.; Xu, Y.; Yang, B.; Tiruchinapally, G.; Sun, B.; Liu, R.; Dulaney, S.; Liu, J.; Huang, X. Preactivation-Based, One-Pot Combinatorial Synthesis of Heparin-like Hexasaccharides for the Analysis of Heparin-Protein Interactions; Chem. Eur. J. 2010, 16, 8365-8375 and references cited therein.
147. Chan, W. C. W.; Nie, S. Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection; Science 1998, 281, 2016-2018. (Pubitemid 28475486)
148. Kikkeri, R.; Lepenies, B.; Adibekian, A.; Laurino, P.; Seeberger, P. H. In vitro Imaging and in vivo Liver Targeting with Carbohydrate Capped Quantum Dots; J. Am. Chem. Soc. 2009, 131, 2110-2112.
149. Bhang, S. H.; Won, N.; Lee, T.-J.; Jin, H.; Nam, J.; Park, J.; Chung, H.; Park, H.-S.; Sung, Y.-E.; Hahn, S. K.; Kim, B.-S.; Kim, S. Hyaluronic Acid- Quantum Dot Conjugates for in vivo Lymphatic Vessel Imaging; ACS Nano 2009, 3, 1389-1398.
150. Jiang, X.; Ahmed, M.; Deng, Z.; Narain, R. Biotinylated Glycofunctionalized Quantum Dots: Synthesis, Characterization, and Cytotoxicity Studies; Bioconjugate Chem. 2009, 20, 994-1001.
151. Babu, P.; Sinha, S.; Surolia, A. Sugar-Quantum Dot Conjugates for a Selective and Sensitive Detection of Lectins; Bioconjugate Chem. 2007, 18, 146-151. (Pubitemid 46146004)
152. Svarovsky, S. A.; Barchi, J. J., Jr. De novo Synthesis of Biofunctional Carbohydrate-encapsulated Quantum Dots; Demchenko, A. V., Ed., Ed.; Oxford University Press: New York, NY, 2007, p 375-394.
153. Oh, E.; Lee, D.; Kim, Y.-P.; Cha, S. Y.; Oh, D.-B.; Kang, H. A.; Kim, J.; Kim, H.-S. Nanoparticle-based Energy Transfer for Rapid and Simple Detection of Protein Glycosylation; Angew. Chem. Int. Ed. 2006, 45, 7959-7963. (Pubitemid 44912751)
154. de la Fuente, J. M.; Penadés, S. Glyco-quantum Dots: a New Luminescent System with Multivalent Carbohydrate Display; Tetrahedron Asymm. 2005, 16, 387-391. (Pubitemid 40178758)
155. Robinson, A.; Fang, J.-M.; Chou, P.-T.; Liao, K.-W.; Chu, R.-M.; Lee, S.-J. Probing Lectin and Sperm with Carbohydrate-modified Quantum Dots; ChemBioChem 2005, 6, 1899-1905. (Pubitemid 41475283)
156. Sun, X.-L.; Cui, W.; Haller, C.; Chaikof, E. L. Site-specific Multivalent Carbohydrate Labeling of Quantum Dots and Magnetic Beads; ChemBioChem 2004, 5, 1593-1596. (Pubitemid 39531677)
157. Mukhopadhyay, B.; Martins, M.; Karamanska, R.; Russell, D. A.; Field, R. A. Bacterial Detection Using Carbohydrate-functionalised CdS Quantum Dots: a Model Study Exploiting E. coli Recognition of Mannosides; Tetrahedron Lett. 2009, 50, 886-889.
158. Osaki, F.; Kanamori, T.; Sando, S.; Sera, T.; Aoyama, Y. A Quantum Dot
159. Kim, K.; Hur, W.; Park, S.-J.; Hong, S. W.; Choi, J. E.; Goh, E. J.; Yoong, S. K.; Hahn, S. K. Bioimaging for Targeted Delivery of Hyaluronic Acid Derivatives to the Livers in Cirrhotic Mice Using Quantum Dots; ACS Nano 2010, 4, 3005-3014.
160. Kikkeri, R.; Laurino, P.; Odedra, A.; Seeberger, P. H. Synthesis of Carbohydrate-functionalized Quantum Dots in Microreactors; Angew. Chem. Int. Ed. 2010, 49, 2054-2057.
161. Wu, P.; Chen, X.; Hu, N.; Tam, U. C.; Blixt, O.; Zettl, A.; Bertozzi, C. R. Biocompatible Carbon Nanotubes Generated by Functionalization with Glycodendrimers; Angew. Chem. Int. Ed. 2008, 47, 5022-5025.
162. Chen, X.; Tam, U. C.; Czlapinski, J. L.; Lee, G. S.; Rabuka, D.; Zettl, A.; Bertozzi, C. R. Interfacing Carbon Nanotubes with Living Cells; J. Am. Chem. Soc. 2006, 128, 6292-6293. (Pubitemid 43727247)
163. Chen, X.; Lee, G. S.; Zettl, A.; Bertozzi, C. R. Biomimetic Synthesis: Biomimetic Engineering of Carbon Nanotubes by Using Cell Surface Mucin Mimics; Angew. Chem. Int. Ed. 2004, 43, 6111-6116.
164. Gu, L.; Luo, P.; Wang, H.; Meziani, M. J.; Lin, Y.-S.; Veca, L. M.; Cao, L.; Lu, F.; Wang, X.; Quinn, R. A.; Wang, W.; Zhang, P.; Lacher, S.; Sun, Y.-P. Single-Walled Carbon Nanotube as a Unique Scaffold for the Multivalent Display of Sugars; Biomacromolecules 2008, 9, 2408-2418.
165. Gu, L.; Elkin, T.; Jiang, X.; Li, H.; Lin, Y.; Qu, L.; Tzeng, T. R. J.; Joseph, R.; Sun, Y. P. Single-walled Carbon Nanotubes Displaying Multivalent Ligands for Capturing Pathogens; Chem. Commun. 2005, 874-876. (Pubitemid 40313260)
166. Luo, P. G.; Wang, H.; Gu, L.; Lu, F.; Lin, Y.; Christensen, K. A.; Yang, S.- T.; Sun, Y.-P. Selective Interactions of Sugar-Functionalized Single-Walled Carbon Nanotubes with Bacillus Spores; ACS Nano 2009, 3, 3909-3916.
167. Wang, H.; Gu, L.; Lin, Y.; Lu, F.; Meziani, M. J.; Luo, P. G.; Wang, W.; Cao, L.; Sun, Y. P. Unique Aggregation of Anthrax (Bacillus anthracis) Spores by Sugar-Coated Single-Walled Carbon Nanotubes; J. Am. Chem. Soc. 2006, 128, 13364-13365. (Pubitemid 44583014)
168. Astruc, D.; Boisselier, E.; Ornelas, C. Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine; Chem. Rev. 2010, 110, 1857-1959.
169. Bosman, A. W.; Janssen, H. M.; Meijer, E. W. About Dendrimers: Structure, Physical Properties, and Applications; Chem. Rev. 1999, 99, 1665-1688. (Pubitemid 129585157)
170. Turnbull, W. B.; Stoddart, J. F. Design and Synthesis of Glycodendrimers; Rev. Mol. Biotechnol. 2002, 90, 231-255. (Pubitemid 34179576)
171. Roy, R. Glycodendrimers. A new class of biopolymers; Polym. News 1996, 21, 226-232.
172. Page, D.; Zanini, D.; Roy, R. Macromolecular Recognition: Effect of Multivalency in the Inhibition of Binding of Yeast Mannan to Concanavalin A and Pea Lectins by Mannosylated Dendrimers; Bioorg. Med. Chem. 1996, 4, 1949-1961. (Pubitemid 26426953)
173. Andre, S.; Pieters, R. J.; Vrasidas, I.; Kaltner, H.; Kuwabara, I.; Liu, F.-T.; Liskamp, R. M. J.; Gabius, H.-J. Wedgelike Glycodendrimers as Inhibitors of Binding of Mammalian Galectins to Glycoproteins, Lactose Maxiclusters, and Cell Surface Glycoconjugates; ChemBioChem 2001, 2, 822-830. (Pubitemid 33722674)
174. Pieters, R. J. Maximizing Multivalency Effects in Protein-carbohydrate Interactions; Org. Biomol. Chem. 2009, 7, 2013-2025.
175. Pieters, R. J.; Liskamp, R. M. J. Multivalent Presentation Strategies in Novel Inhibitors of Bacterial (toxin) Adhesion and Synthetic Vaccines; Anti-Infect. Agents Med. Chem. 2008, 7, 193-200.
176. Sisu, C.; Baron, A. J.; Branderhorst, H. M.; Connell, S. D.; Weijers, C. A. G. M.; de Vries, R.; Hayes, E. D.; Pukin, A. V.; Gilbert, M.; Pieters, R. J.; Zuilhof, H.; Visser, G. M.; Turnbull, W. B. The Influence of Ligand Valency on Aggregation Mechanisms for Inhibiting Bacterial Toxins; ChemBioChem 2009, 10, 329-337.
177. Deguise, I.; Lagnoux, D.; Roy, R. Synthesis of Glycodendrimers Containing Both Fucoside and Galactoside Residues and Their Binding Properties to PA-IL and PA-IIL Lectins from Pseudomonas Aeruginosa; New J. Chem. 2007, 31, 1321-1331. (Pubitemid 47036640)
178. Touaibia, M.; Wellens, A.; Shiao, T. C.; Wang, Q.; Sirois, S.; Bouckaert, J.; Roy, R. Mannosylated G(0) Dendrimers with Nano-molar Affinities to Escherichia coli FimH; ChemMedchem 2007, 2, 1190-1201.
179. Schlick, K. H.; Udelhoven, R. A.; Strohmeyer, G. C.; Cloninger, M. J. Binding of Mannose-functionalized Dendrimers with Pea (Pisum sativum) Lectin; Mol. Pharm. 2005, 2, 295-301. (Pubitemid 41186405)
180. Mangold, S. L.; Morgan, J. R.; Strohmeyer, G. C.; Gronenborn, A. M.; Cloninger, M. J. Cyanovirin-N Binding to Man1-2Man Functionalized Dendrimers; Org. Biomol. Chem. 2005, 3, 2354-2358. (Pubitemid 41100389)
181. Wolfenden, M. L.; Cloninger, M. J. Mannose/glucose-functionalized Dendrimers to Investigate the Predictable Tunability of Multivalent Interactions; J. Am. Chem. Soc. 2005, 127, 12168-12169 and references therein. (Pubitemid 41279210)
182. Wolfenden, M. L.; Cloninger, M. J. Carbohydrate-functionalized Dendrimers to Investigate the Predictable Tunability of Multivalent Interactions; Bioconjugate Chem. 2006, 17, 958-966 and references therein. (Pubitemid 44162614)
183. Woller, E. K.; Walter, E. D.; Morgan, J. R.; Singel, D. J.; Cloninger, M. J. Altering the Strength of Lectin Binding Interactions and Controlling the Amount of Lectin Clustering Using Mannose/hydroxyl-functionalized Dendrimers; J. Am. Chem. Soc. 2003, 125, 8820-8826. (Pubitemid 36886219)
184. Woller, E. K.; Cloninger, M. J. The Lectin-binding Properties of Six Generations of Mannose-functionalized Dendrimers; Org. Lett. 2002, 4, 7-10.
185. Seah, N.; Santacroce, P. V.; Basu, A. Probing the Lactose·GM3 Carbohydrate-Carbohydrate Interaction with Glycodendrimers; Org. Lett. 2009, 11, 559-562.
186. Mak, R. H.; Kuo, H.-J. Pathogenesis of Urinary Tract Infection: an Update; Curr. Opin. Pediatr. 2006, 18, 148-52.
187. Palmer, L. M.; Reilly, T. J.; Utsalo, S. J.; Donnenberg, M. S. Internalization of Escherichia coli by Human Renal Epithelial Cells is Associated with Tyrosine Phosphorylation of Specific Host Cell Proteins; Infect. Immun. 1997, 65, 2570-2575. (Pubitemid 27264079)
188. Sharon, N. Carbohydrates as Future Anti-adhesion Drugs for Infectious Diseases; Biochim. Biophys. Acta 2006, 1760, 527-537.
189. Wellens, A.; Garofalo, C.; Nguyen, H.; van Gerven, N.; Slattegard, R.; Hernalsteens, J.-P.; Wyns, L.; Oscarson, S.; de Greve, H.; Hultgren, S.; Bouckaert, J. Intervening with Urinary Tract Infections Using Anti-adhesives Based on the Crystal Structure of the FimH-oligomannose-3 Complex; PLoS One 2008, 3, 4.
190. Choudhury, D.; Thompson, A.; Stojanoff, V.; Langermann, S.; Pinkner, J.; Hultgren, S. J.; Knight, S. D. X-ray Structure of the FimC-FimH Chaperoneadhesin Complex from Uropathogenic Escherichia coli; Science 1999, 285, 1061-1066.
191. Firon, N.; Ofek, I.; Sharon, N. Interaction of Mannose-containing Oligosaccharides with the Fimbrial Lectin of Escherichia coli; Biochem. Biophys. Res. Commun. 1982, 105, 1426-1432. (Pubitemid 13222588)
192. Firon, N.; Ashkenazi, S.; Mirelman, D.; Ofek, I.; Sharon, N. Aromatic Alpha-glycosides of Mannose are Powerful Inhibitors of the Adherence of Type 1 Fimbriated Escherichia coli to Yeast and Intestinal Epithelial Cells; Infect. Immun. 1987, 55, 472-476. (Pubitemid 17004131)
193. Nagahori, N.; Lee, R. T.; Nishimura, S.-I.; Page, D.; Roy, R.; Lee, Y. C. Inhibition of Adhesion of Type 1 Fimbriated Escherichia coli to Highly Mannosylated Ligands; ChemBioChem 2002, 3, 836-844. (Pubitemid 36002300)
194. Salminen, A.; Loimaranta, V.; Joosten, J. A. F.; Khan, A. S.; Hacker, J.; Pieters, R. J.; Finne, J. Inhibition of P-fimbriated Escherichia coli Adhesion by Multivalent Galabiose Derivatives Studied by a Live-bacteria Application of Surface Plasmon Resonance; J. Antimicrob. Chemother. 2007, 60, 495-501. (Pubitemid 47299862)
195. Branderhorst, H. M.; Kooij, R.; Salminen, A.; Jongeneel, L. H.; Arnusch, C. J.; Liskamp, R. M. J.; Finne, J.; Pieters, R. J. Synthesis of Multivalent Streptococcus suis Adhesion Inhibitors by Enzymatic Cleavage of Polygalacturonic Acid and 'Click' Conjugation; Org. Biomol. Chem. 2008, 6, 1425-1434. (Pubitemid 351469861)
196. Joosten, J., A. F.; Loimaranta, V.; Appeldoorn, C. C. M.; Haataja, S.; El Maate, F. A.; Liskamp, R. M. J.; Finne, J.; Pieters, R. J. Inhibition ofStreptococcus suis Adhesion by Dendritic Galabiose Compounds at Low Nanomolar Concentration; J. Med. Chem. 2004, 47, 6499-6508. (Pubitemid 39657312)
197. Hansen, H. C.; Haataja, S.; Finne, J.; Magnusson, G. Di-, Tri-, and Tetravalent Dendritic Galabiosides that Inhibit Hemagglutination by Streptococcus suis at Nanomolar Concentration; J. Am. Chem. Soc. 1997, 119, 6974-6979. (Pubitemid 27357285)
198. Rojo, J.; Delgado, R. Glycodendritic Structures: Promising New Antiviral Drugs; J. Antimicrob. Chemother. 2004, 54, 579-581. (Pubitemid 39263896)
199. Lasala, F.; Arce, E.; Otero, J. R.; Rojo, J.; Delgado, R. Mannosyl Glycodendritic Structure Inhibits DC-SIGN-Mediated Ebola Virus Infection in cis and in trans; Antimicrob. Agents Chemother. 2003, 47, 3970-3972. (Pubitemid 37485018)
200. Roy, R.; Baek, M.-G.; Rittenhouse-Olson, K. Synthesis of N,N¢- bis(Acrylamido)acetic Acid-Based T-Antigen Glycodendrimers and Their Mouse Monoclonal IgG Antibody Binding Properties; J. Am. Chem. Soc. 2001, 123, 1809-1816. (Pubitemid 32199997)
201. Thoma, G.; Streiff, M. B.; Katopodis, A. G.; Duthaler, R. O.; Voelcker, N. H.; Ehrhardt, C.; Masson, C. Non-Covalent Polyvalent Ligands by Self- Assembly of Small Glycodendrimers: A Novel Concept for the Inhibition of Polyvalent Carbohydrate-Protein Interactions In vitro and In vivo; Chem. Eur. J. 2006, 12, 99-117. (Pubitemid 43004108)
202. Thoma, G.; Katopodis, A. G.; Voelcker, N. H.; Duthaler, R. O.; Streiff, M. B. Novel Glycodendrimers Self-Assemble to Nanoparticles which Function as Polyvalent Ligands In vitro and In vivo; Angew. Chem. Int. Ed. 2002, 41, 3195-3198. (Pubitemid 35014384)
203. Shaunak, S.; Thomas, S.; Gianasi, E.; Godwin, A.; Jones, E.; Teo, I.; Mireskandari, K.; Luthert, P.; Duncan, R.; Patterson, S.; Khaw, P.; Brocchini, S. Polyvalent Dendrimer Glucosamine Conjugates Prevent Scar Tissue Formation; Nature Biotech. 2004, 22, 977-984. (Pubitemid 39014474)
204. Krist, P.; Herkommerová -Rajnochová, E.; Rauvolfová, J.; Semeňuk, T.; Vavručková, P.; Pavlíček, J.; Bezoučka, K.; Petruč, L.; Krěn, V. Toward an Optimal Oligosaccharide Ligand for Rat Natural Killer Cell Activation Receptor NKR-P1; Biochem. Biophys. Res. Commun. 2001, 287, 11-20. (Pubitemid 32916117)
205. Krist, P.; Vannucci, L.; Kuzma, M.; Man, P.; Sadalapure, K.; Patel, A.; Bezoučka, K.; Pospíčil, M.; Petruč, L.; Lindhorst, T. K.; Krěn, V. Fluorescent Labelled Thiourea-Bridged Glycodendrons; ChemBioChem 2001, 5, 445-452. (Pubitemid 39257100)
206. Bezoučka, K.; Krěn, V.; Kieburg, C.; Lindhorst, T. K. GlcNAc-terminated Glycodendrimers Form Defined Precipitates with the Soluble Dimeric Receptor of Rat Natural Killer Cells, sNKR-P1A; FEBS Lett. 1998, 426, 243-247. (Pubitemid 28198135)
207. Vannucci, L.; Fiserová, A.; Sadalapure, K.; Lindhorst, T. K.; Kuldová, M.; Rossmann, P.; Horváth, O.; Krěn, V.; Krist, P.; Bezoučka, K.; Luptovcová, M.; Mosca, F.; Pospíč il, M.; Krěn, V. Effects of N-acetyl-glucosaminecoated Glycodendrimers as Biological Modulators in the B16F10 Melanoma Model in vivo; Int. J. Oncol. 2003, 23, 285-296.
208. Hulikova, K.; Benson, V.; Svoboda, J.; Sima, P.; Fiserova, A. N-Acetyl-Dglucosamine- coated Polyamidoamine Dendrimer Modulates Antibody Formation via Natural Killer Cell Activation; Int. Immunopharmacol. 2009, 9, 792-799.